Intriguingly, at early stage of cancer development, TGF-β signaling rather provides cell growth inhibitory function12, owing to increased expression of CDK inhibitor p15INK4B, p21CIP41, and p57KIP213. The gene discussed is TGFB1; the disease is cancer.